FindTrial
Sign In

ECG and Cardiac enzyme changes in patients with Stroke

Electrocardiogram Changes and Cardiac Biomarkers : Association with Localization and Severity in Acute Ischemic Stroke.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046255
Enrollment
30
Registered
2022-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I63- Cerebral infarction

Interventions

None listed

Sponsors

Antony Jose
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients admitted within 24 hours of onset of symptoms of acute ischemic stroke.

Exclusion criteria

Exclusion criteria: Hemorrhagic stroke. Cardioembolic stroke ââ?¬â?? as evidenced by prior history of valvular or ischemic heart disease, or cardia arrhythmias,cardiac surgery. Echocardiogram at admission revealing valvular heart disease, atrial thrombus, regional wall motion abnormality or ejection fraction less than 50%

Design outcomes

Primary

MeasureTime frame
Monitoring of cardiac enzymes would guide prevention and treatment of cardiac disease in patients with stroke. Patients with greater biomarker elevation may be considered for early coronary evaluation and interventionTimepoint: 1 year—

Secondary

MeasureTime frame
Elevated biomarkers would help in stroke prognostication.Timepoint: 1 year—

Countries

India

Contacts

Public ContactANTONY JOSE

Father Muller Medical College

antonyjose92@gmail.com09448367253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026